Related Experiment Video
Updated: Apr 27, 2026

A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos
Published on: November 8, 2014
Fishing for targets: novel approaches using small molecule baits
Katrin Szardenings1, Bei Li1, Lifu Ma1
1ActivX Biosciences, 11025 N. Torrey Pines Road, La Jolla, CA 92037, USA.
New proteomic tools and analytical techniques enable novel approaches for identifying drug targets and off-targets. Advances in activity-based probes enhance understanding of small molecule interactions in biological systems.
Area of Science:
- Biochemistry
- Chemical Biology
- Drug Discovery
Background:
- Emerging technologies are revolutionizing target identification in drug discovery.
- Novel proteomic tools and analytical techniques are key drivers of innovation.
- Understanding molecular interactions is crucial for effective drug development.
Purpose of the Study:
- To highlight recent advancements in target identification technologies.
- To discuss the application of new approaches in drug discovery.
- To emphasize the role of activity-based probes in understanding molecular interactions.
Main Methods:
- Application of three novel approaches for target and off-target determination.
- Utilizing advanced analytical techniques for molecular analysis.
- Employing activity-based probes for live-cell labeling.
Main Results:
- Successful application of new technologies in drug discovery efforts.
- Identification of both intended targets and unintended off-targets.
- Enhanced understanding of small molecule-biological system interactions at the molecular level.
Conclusions:
- Novel technologies significantly improve target identification accuracy.
- Activity-based probes offer deeper insights into drug mechanisms.
- These advancements accelerate the drug discovery and development pipeline.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013